Processa Pharmaceuticals ... (PCSA)
NASDAQ: PCSA
· Real-Time Price · USD
0.33
0.03 (9.78%)
At close: Jun 09, 2025, 3:59 PM
Processa Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.9M | 1.19M | 2.89M | 5.57M | 8.92M | 4.71M | 6.86M | 8.68M | 10.74M | 6.5M | 9.05M | 12.06M | 14.39M | 16.5M | 19.09M | 20.83M | 23.05M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.15M | n/a | n/a | n/a |
Other Long-Term Assets | 941.25K | 1.28M | 5.54K | 5.54K | 5.54K | 5.53K | 5.54K | 5.54K | 5.54K | 5.54K | 5.54K | 5.54K | 5.54K | -2.14M | 5.54K | 5.54K | 5.54K |
Receivables | n/a | n/a | n/a | n/a | 22.3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 70.27K | 70.27K | 70.27K | 73.84K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 860.81K | 682.29K | 1.95M | 1.91M | 857.63K | 926.3K | 1.05M | 1.22M | 1.48M | 1.88M | 1.83M | 1.9M | 1.99M | n/a | n/a | n/a | n/a |
Total Current Assets | 3.76M | 1.87M | 4.84M | 7.48M | 9.8M | 5.63M | 7.91M | 9.9M | 12.22M | 8.39M | 10.89M | 13.96M | 16.38M | 18.33M | 20.67M | 22.57M | 24.55M |
Property-Plant & Equipment | 52.45K | 75.69K | 98.48K | 117.47K | 138.9K | 148.61K | 169.73K | 187.6K | 207.79K | 227.59K | 246.98K | 28.89K | 51.62K | 74.18K | 95.93K | 117.24K | 138.11K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.47M | 7.66M | 7.86M | 8.06M | 8.25M | 8.45M | 8.65M |
Total Long-Term Assets | 993.7K | 1.36M | 104.01K | 123K | 144.44K | 154.15K | 175.26K | 193.14K | 213.32K | 233.12K | 7.72M | 7.7M | 7.92M | 8.14M | 8.36M | 8.57M | 8.79M |
Total Assets | 4.81M | 3.23M | 4.94M | 7.6M | 9.94M | 5.79M | 8.08M | 10.09M | 12.43M | 8.62M | 18.6M | 21.66M | 24.3M | 26.46M | 29.03M | 31.14M | 33.34M |
Account Payables | 552.56K | 880.88K | 711.71K | 953.09K | 455.37K | 311.62K | 346.3K | 239.02K | 316.71K | 327.55K | 311.07K | 648.1K | 316.09K | 218.91K | 354.98K | 287.88K | 177.02K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -26.55K | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 49.66K | n/a | 94.68K | 93.18K | n/a | 83.65K | 82.74K | 81.89K | 81.17K | 78.9K | 76.26K | 26.55K | 49.12K | 71.08K | 92.77K | 92.45K | 144.89K |
Other Current Liabilities | 680.75K | n/a | 412.81K | -93.18K | n/a | 105.39K | 112.05K | 107.11K | -81.17K | 110.16K | 512.74K | 562.45K | 350.88K | 330.69K | 307.23K | 319.3K | 441.26K |
Total Current Liabilities | 1.28M | 1.53M | 1.22M | 1.55M | 1.01M | 730.58K | 826.07K | 821.41K | 2.16M | 998.56K | 1.19M | 1.57M | 1.06M | 971.02K | 1.23M | 1.16M | 1.1M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.57K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 400K | 400K | 400K |
Total Long-Term Liabilities | n/a | 487.00 | 2.17K | 25.65K | 50.7K | 66.9K | 88.78K | 109.33K | 129.36K | 150.55K | 171.71K | 4.66K | 6.15K | 7.38K | 590.52K | 735.09K | 906.38K |
Total Liabilities | 1.28M | 1.53M | 1.22M | 1.58M | 1.06M | 797.48K | 914.85K | 930.74K | 2.29M | 1.15M | 1.36M | 1.58M | 1.06M | 978.4K | 1.82M | 1.9M | 2M |
Total Debt | 49.66K | 73.51K | 96.84K | 118.83K | 140.38K | 150.55K | 171.52K | 191.22K | 210.52K | 229.45K | 247.97K | 31.21K | 55.27K | 78.46K | 101.54K | 123.34K | 307.17K |
Common Stock | 527.00 | 371.00 | 327.00 | 287.00 | 286.00 | 129.00 | 2.47K | 2.46K | 2.46K | 1.61K | 1.6K | 1.59K | 1.59K | 1.57K | 1.56K | 1.56K | 1.55K |
Retained Earnings | -90.05M | -87.22M | -84.49M | -81.11M | -78.1M | -75.37M | -72.96M | -70.88M | -68.27M | -64.25M | -51.24M | -45.21M | -40.05M | -36.82M | -33.64M | -30.65M | -27.5M |
Comprehensive Income | n/a | n/a | n/a | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | 0.00 | 0.00 | n/a | -0.00 | n/a |
Shareholders Equity | 3.53M | 1.7M | 3.72M | 6.02M | 8.88M | 4.99M | 7.17M | 9.16M | 10.14M | 7.47M | 17.24M | 20.08M | 23.24M | 25.49M | 27.21M | 29.24M | 31.34M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |